Singapore Markets closed
Straits Times Index
3,262.54 +7.00 (+0.22%) S&P 500
3,971.27 -6.26 (-0.16%) Dow
32,394.25 -37.83 (-0.12%) Nasdaq
11,716.08 -52.76 (-0.45%) BTC-USD
28,356.03 +1,431.11 (+5.32%) CMC Crypto 200
618.56 +375.88 (+154.89%)
Relay Therapeutics, Inc. (RLAY)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 15.48 |
| Open | 15.34 |
| Bid | 13.63 x 800 |
| Ask | 20.20 x 800 |
| Day's range | 14.77 - 15.51 |
| 52-week range | 12.65 - 35.36 |
| Volume | |
| Avg. volume | 1,261,110 |
| Market cap | 1.813B |
| Beta (5Y monthly) | 1.25 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.84 |
| Earnings date | 03 May 2023 - 08 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 35.00 |
- Zacks
Relay Therapeutics, Inc. (RLAY) Reports Q4 Loss, Misses Revenue Estimates
Relay Therapeutics, Inc. (RLAY) delivered earnings and revenue surprises of 21.13% and 66.27%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Aurinia Pharmaceuticals (AUPH) Expected to Beat Earnings Estimates: Should You Buy?
Aurinia (AUPH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Earnings Preview: Relay Therapeutics, Inc. (RLAY) Q4 Earnings Expected to Decline
Relay Therapeutics, Inc. (RLAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2023 Yahoo. All rights reserved.
